City of Hope

This is your central portal for breaking news, the latest research and important updates from City of Hope. Bookmark this page and check back often for updates.

Association of Community Cancer Centers announces award recipients

August 30, 2019
The Association of Community Cancer Centers will present awards to three oncology professionals at its 36th National Oncology Conference, which will…

$9 million grant funds trial of CAR T-cell therapy for metastatic breast cancer

August 25, 2019
California Institute for Regenerative Medicine awarded a $9.28 million grant will support a clinical trial at City of Hope to evaluate chimeric…
In the JournalsPerspective

Cancer screening rates ‘unexpectedly high’ among adults aged 85 years and older

August 7, 2019
Individuals aged 85 years and older underwent cancer screening at “unexpectedly high” rates even though it is generally not recommended…
FDA News

Mustang Bio’s CAR T-cell therapy receives orphan drug designation for AML

July 25, 2019
The FDA has granted orphan drug designation to MB-102, an investigational chimeric antigen receptor T-cell therapy for patients with acute myeloid…
FDA NewsPerspective

At FDA’s request, Allergan recalls breast implants linked to rare lymphoma

July 24, 2019
In response to a request from FDA, Allergan recalled specific models of its textured breast implants due to a potential risk for breast…
Molecular Oncology

Mind the gap: Precision medicine shortcomings in NSCLC

HemOnc Today, July 10, 2019
Howard (Jack) West, MD
This year’s ASCO Annual Meeting included several major successes that should translate to new molecular targets in advanced non-small cell lung…

City of Hope appoints hematologists to new roles

July 3, 2019
Two hematologists at City of Hope have been appointed to new positions. Larry Kwak, MD, PhD, has been named deputy director of City of…
Meeting News

Investigational CAR T-cell therapy induces durable responses in pretreated leukemia subtypes

June 24, 2019
CHICAGO — Heavily pretreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma and prior ibrutinib treatment achieved…
In the Journals

Tumor mutational burden may guide treatment decisions in metastatic colorectal cancer

June 19, 2019
Tumor mutational burden appeared to independently predict which patients with microsatellite instability-high metastatic colorectal cancer would…
Meeting News

Conquer Cancer Foundation presents Merit Awards at ASCO

June 6, 2019
CHICAGO — The Conquer Cancer Foundation of ASCO presented ASCO Annual Meeting Merit Awards to more than 100 oncology professionals. The awards…

City of Hope provost admitted into Association of American Physicians

May 20, 2019
Steven T. Rosen, MD, provost and chief scientific officer at City of Hope, has been admitted into the Association of American Physicians. The…
In the JournalsPerspective

Functional impairment linked to higher mortality among older adults with hematologic malignancies

May 9, 2019
Older adults with hematologic malignancies who require assistance with at least one basic or instrumental daily living activity have a higher risk…

‘We have to cure’ cancer, says CAR T pioneer Carl H. June, MD

April 18, 2019
Carl H. June , MD, is about to receive an award for his life’s work — it's not his first and it certainly won’t…

Trial explores T-cell therapy’s role in personalized treatment for lung cancer

April 4, 2019
ATLANTA — In the battle against non-small cell lung cancer, the ability to personalize treatment may be a key to victory, according to Karen

City of Hope professors receive honors

February 23, 2019
Three members of the faculty at City of Hope received awards in recognition of their contributions to the field of oncology. Alexandra

Trial to assess CAR T-cell therapy for HER2-positive metastatic breast cancer

January 19, 2019
Researchers at City of Hope have opened a first-in-human clinical trial to assess the use of chimeric antigen receptor T-cell therapy for patients…
Meeting NewsPerspective

Novel risk stratification model outperforms standard prediction tools for myelodysplastic syndrome

December 3, 2018
SAN DIEGO — A personalized risk prediction model developed using machine learning showed utility as a predictive and prognostic tool among…
Meeting NewsPerspective

Ibrutinib plus CD19-specific CAR T-cell therapy may benefit patients with relapsed or refractory CLL

December 2, 2018
SAN DIEGO — Administration of ibrutinib beginning 2 weeks prior to leukapheresis and continuing until 3 months after CD19-specific chimeric…

Arti Hurria, MD, remembered as ‘true giant’ in oncology, tireless advocate for patients

November 15, 2018
Arti Hurria, MD, felt she found her perfect fit in the field of medicine. The colleagues who continue to express an overwhelming sense of personal…

Oncologists, hematologists elected to National Academy of Medicine

October 18, 2018
The National Academy of Medicine announced the election of 75 regular members and 10 international members. Election to the academy —…